Flavin-containing monooxygenase (FMO), a family of NADPH-and FAD-dependent enzymes, plays important roles in oxygenation of various nitrogen-, sulfur-, and phosphorous-containing xenobiotics, such as drugs, pesticides, and industrial chemicals. Cynomolgus FMO3 is predominantly expressed in liver and catalyzes substrates of human FMO3 similar to the human ortholog. In contrast, cynomolgus FMO1 has not been characterized in kidneys.
6
In cynomolgus macaques (Macaca fascicularis), an important primate species widely used in drug metabolism studies, the orthologs of the five human FMOs have been identified and characterized. 7 Cynomolgus FMO3 is predominantly expressed in liver and catalyzes substrates of human FMO3 similar to the human ortholog. In contrast, cynomolgus FMO1 has not been characterized in kidneys.
Thus, this study investigated the expression and metabolic activity of cynomolgus FMO1 in kidneys.
| MATERIAL S AND ME THODS

| Materials
Kidney samples were collected from six cynomolgus macaques (three males and three females, 4-5 years of age, 3-5 kg), and kidney microsomes were prepared as described previously (Uehara et al, 2017). This study was reviewed and approved by the Institutional Animal Care and Use Committee of Shin Nippon Biomedical Laboratories, Ltd. Cynomolgus FMO1 protein was heterologously expressed in Escherichia coli, and membrane preparations were carried out as described previously. 7 Human kidney microsomes were purchased from Biopredic International (Rennes, France).
Benzydamine was purchased from Sigma-Aldrich (St. Louis, MO).
Anti-human FMO1 antibody and horseradish peroxidase-conjugated goat anti-rabbit IgG were purchased from BD Gentest (Woburn, MA). Anti-histidine tag antibody was purchased from BioDynamics Lab. (Tokyo, Japan). All other reagents were purchased from SigmaAldrich or Wako Pure Chemicals (Osaka, Japan), unless otherwise specified.
| Immunoblotting
Immunoblotting was performed as described previously 8 using
anti-human FMO1 antibody in cynomolgus and human kidney microsomes, and cynomolgus FMO1 protein. Briefly, the proteins were separated on 7.5% SDS polyacrylamide gels and transferred to nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA).
After blocking, the filters were incubated with the primary antibodies and then the secondary antibodies. The signals were detected using an ECL Prime Western blotting detection reagent (GE Healthcare, Buckinghamshire, UK) according to the manufacturer's instructions.
| Drug-metabolizing enzyme assays
Rates of N-oxygenation of benzydamine were measured by liquid chromatography methods described previously. 8 
| RE SULTS AND D ISCUSS I ON
Immunoblotting was performed to detect expression of cynomol- and FMO3 mRNAs in kidney and liver, respectively. 7 Moreover, in kidney and liver, FMO1 and FMO3 mRNAs are the most abundant of all FMO mRNAs. 7 In contrast, other species express FMO1 in livers, including pig, 9 dog, 10 rabbit, 11 rat, 12 and mouse. 13, 14 Moreover, FMO3 mRNA is expressed in adult female mouse livers, but not in male 14 , and differential tissue expression would complicate extrapolation of data to humans. Therefore, cynomolgus macaque could be a species more suitable for FMO-mediated drug metabolism studies.
Rates of benzydamine N-oxygenation in kidney microsomes were variable among the six cynomolgus macaques analyzed (Figure 2 16, 17 although the extent of the variability differs between the two studies. In conclusion, cynomolgus FMO1 was expressed and functional in kidneys, similar to human FMO1.
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